ADVFN ADVFN

Hot Features

Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
NewcelX Ltd

NewcelX Ltd (NCEL)

3.55
-0.04
(-1.11%)
終値: 6月26日 5:00AM
3.55
0.00
( 0.00% )
取引時間後: 5:30AM

NewcelX Ltd (NCEL) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

主要統計と詳細

通貨
3.55
( -1.11% )
買値
1.83
売値
4.32
出来高
4,417
3.4268 日の範囲 3.595
1.8299 52 週間の範囲 6.48
時価総額
前日終値
3.59
始値
3.50
時刻
1
@
3.55
最終取引時間
05:10:05
財務取引量
US$ 15,331
VWAP
3.471
平均取引量 (3 か月)
US$ 52,839
発行済株式数
5,383,871
配当利回り
PER
-1.62
1 株当たり利益 (EPS)
-2.16
歳入
-
純利益
-8.3M

NewcelX Ltd について

NewcelX Ltd., a biopharmaceutical company, engages in developing transformative stem-cell-derived therapies for Diabetes. The company develops NCEL-101, a cellular therapy product based on enriched pancreatic islet-like clusters for the treatment of Type 1 diabetes and Type 2 insulin dependent diabe... NewcelX Ltd., a biopharmaceutical company, engages in developing transformative stem-cell-derived therapies for Diabetes. The company develops NCEL-101, a cellular therapy product based on enriched pancreatic islet-like clusters for the treatment of Type 1 diabetes and Type 2 insulin dependent diabetes; AstroRx, an off-the-shelf cryopreserved cell therapy product for the treatment of Amyotrophic Lateral Sclerosis and neurodegenerative indications; and Dual Orexin-Receptor Agonist (DOXA), a small molecules platform for the treatment of sleep disorders, Neurodegenerative/ neuroinflammation diseases, and Diabetes Associated Neurological Disorders. It also develops iTOL-102, NCEL-201, NCEL-301, and NCEL-007. NewcelX Ltd. was founded in 2008 and is headquartered in Kloten, Switzerland. 詳細を表示

セクター
Healthcare
業界
Biotechnology & Life Sciences
ウェブサイト
本社
Kloten, Switzerland
設立
2026
NewcelX Ltd is listed in the Healthcare sector of the ナスダック市場 with ticker NCEL. The last closing price for NewcelX was US$3.59. Over the last year, NewcelX shares have traded in a share price range of US$ 1.8299 to US$ 6.48.

NewcelX currently has 5,383,871 shares in issue. The market capitalisation of NewcelX is US$19.11 million. NewcelX has a price to earnings ratio (PE ratio) of -1.62.

NCEL 最新ニュース

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10.412.69841269843.153.613.14148523.45603797CS
40.216.28742514973.343.612.8199823.34006428CS
121.2554.3478260872.35.122.0615553643.63525886CS
260.9637.06563706562.595.121.8299697902.89970984CS
52-2.18-38.04537521825.736.481.8299740743.24036346CS
156-2.18-38.04537521825.736.481.8299740743.24036346CS
260-2.18-38.04537521825.736.481.8299740743.24036346CS

NCEL - Frequently Asked Questions (FAQ)

What is the current NewcelX Ltd share price?
The current share price of NewcelX Ltd is US$ 3.55
How many NewcelX Ltd shares are in issue?
NewcelX Ltd has 5,383,871 shares in issue
What is the market cap of NewcelX Ltd?
The market capitalisation of NewcelX Ltd is USD 19.11M
What is the 1 year trading range for NewcelX Ltd share price?
NewcelX Ltd has traded in the range of US$ 1.8299 to US$ 6.48 during the past year
What is the PE ratio of NewcelX Ltd?
The price to earnings ratio of NewcelX Ltd is -1.62
What is the registered address of NewcelX Ltd?
The registered address for NewcelX Ltd is Hohstrasse 1, Kloten, 8302
What is the NewcelX Ltd website address?
The website address for NewcelX Ltd is newcelx.com
Which industry sector does NewcelX Ltd operate in?
NewcelX Ltd operates in the Biotechnology & Life Sciences sector

NCEL 取引

さらに

取引は遅延しています

リアルタイムの取引を取得するには、アカウントをアップグレードしてください

リアルタイムにアップグレード

最近閲覧した銘柄